https://research.ouhsc.edu/news Parent Page: News id: -1 Active Page: News id: 26727

OU Health Campus Office of the Vice President for Research

Research News

Laureate Announced for Hamm International Prize for Diabetes Research

The prestigious Harold Hamm International Prize for Biomedical Research in Diabetes, an honor bestowed by OU Health Harold Hamm Diabetes Center at the University of Oklahoma Health Sciences, will be awarded this fall...

Weekly Research Newsletters

Clinical Trial Shows Survival Benefit With Proton Therapy

Results of a Phase III clinical trial published recently in The Lancet show that oropharyngeal cancer patients receiving proton therapy kept their cancer under control just as well as patients...
Read More >

University of Oklahoma, West Virginia University Researchers Earn NIH Grant to Study ‘Concept’ Flavored Cigarillos

Cigarillos, a small type of cigar, have dramatically risen in popularity, particularly those that come in flavors, such as cherry or chocolate. Some state and local laws have banned all flavored...
Read More >

OU Receives $25 Million Grant from TSET to Expand Statewide Cancer Care

The Oklahoma Tobacco Settlement Endowment Trust (TSET) has awarded the University of Oklahoma a $25 million grant to help construct a new OU Health Stephenson Cancer Center facility in Tulsa, a...
Read More >

OU Study Links Genetic Variants to Risk of Blinding Eye Disease in Premature Infants

A new study from the University of Oklahoma suggests that small genetic differences in two proteins – previously known for their role in premature infants’ lungs – may also...
Read More >

GLP-1 Drugs Show Potential Anti-Cancer Effects, Review Article Finds

The success of GLP-1 medications for treating Type 2 diabetes and obesity naturally leads to a related question: Do GLP-1 drugs affect cancer risk, which is often associated with obesity and Type...
Read More >

FDA Grants Fast Track Designation to Drug Combo for Colorectal Cancer

The U.S. Food and Drug Administration has granted Fast Track Designation to a new drug combination for metastatic colorectal cancer, following encouraging results from a clinical trial led in part...
Read More >